Latest Stock Market News

“We have got significant opportunity yet, if you look at the total PCPL portfolio, I think we have got a significant opportunity to restructure and clean up. As part of that the latest thing that we have announced is our whole cleanup of the international and Indian legal listed entities from 43 entities, we are moving down to 23 or to 25.”

Total income of the company rose to Rs 1,674.50 crore in the reporting quarter from Rs 1,061.24 crore in the same period a year ago.

"Gold prices have kept firm trading range ahead of US FOMC meet supported by weaker dollar," Tapan Patel, Senior Analyst (Commodities) at HDFC Securities, said.

Tatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 5047.54 Crore) operating in General sector.

The Relative Strength Index of the stock stood at 54.59 on Wednesday.

As interest rates go up, it hits both the fixed income as well as the equity markets. Let alone anything with credit risk, the proverbially safest investments in the world, US treasuries (government bonds) are down 8.5 per cent for the year!

The scrip on Wednesday traded at Rs 533.65, up 0.88 per cent, but only after falling 24 per cent in the previous four sessions. Brokerage Prabhudas Lilladher said healthy revenue growth was offset by adverse margins.Seasoned investor Dolly Khanna owned 1,081,526 shares or 1.2 per cent stake in this company as of June 30.

A total of 2,303,335 shares changed hands on the counter till 02:05PM (IST).

The stock quoted a 52-week high price of Rs 1356.9 and a 52-week low of Rs 923.5.

“We have a huge plan and this year our capex is a total of Rs 14,000 crore, out of which, majority of nearly Rs 10,000 crore goes for our renewable business. This will be both for the utility scale projects that we are implementing and they are all in the pipeline.”